Skip to content

High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics

Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03039452
Enrollment
15
Registered
2017-02-01
Start date
2017-01-31
Completion date
2017-10-31
Last updated
2017-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

Purpose: The purpose of this study will be to examine the feasibility and acceptability of a 6-week high intensity interval training (HIIT) program in patients with knee OA symptoms ranging from mild to severe. A secondary purpose will be to evaluated changes in whole body metabolism induced by 6-weeks of HIIT. Participants: Fifteen patients (age 40-70 yrs; BMI 20-35 kg/m²) with symptomatic knee OA Procedures (methods): All participants will be assigned to the single-arm of the study in which all participants will receive 6 weeks of HIIT, delivered twice per week. Outcomes will be assessed at baseline and 6 weeks. The primary outcome will evaluate tolerability, feasibility, acceptability, compliance, and adherence to the HIIT program. Secondary outcomes will include whole body metabolism markers, inflammation, and a set of physical function including knee osteoarthritis symptomatic burden and pain, cardiorespiratory fitness, isometric knee extensor and flexor strength (factors associated with physical function and symptomatic knee OA progression), and body composition.

Interventions

BEHAVIORALHigh intensity interval training

Each training session will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Must exhibit symptomatic knee OA (WOMAC \> 31), radiographic evidence of tibiofemoral OA (2-4 Kellgren-Lawrence scale) * Age 40-70 years * Body mass index 20-35 kg/m² * Cleared by study physician from 12 lead EKG and medical history review

Exclusion criteria

* Individuals diagnosed with a cardiovascular condition restricting exercise Individuals currently meeting Department of Health and Human Services Guidelines for Physical Activity (meeting \>150 minutes of exercise per week) * Individuals currently doing HIIT * Individuals currently participating in physical therapy for knee OA * Individuals currently participating in another OA intervention study * Received a corticosteroid or hyaluronic acid injection involved in the knee in the previous 3 weeks or scheduled for during the intervention * Diagnosis of gout in the knee * Diagnosis of Rheumatoid arthritis * Diagnosis of Fibromyalgia * Other systemic rheumatic disease * Severe dementia or other memory loss * Active diagnosis of psychosis or uncontrolled substance abuse disorder * Hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 6 months * Diabetics (medications include exogenous insulin) * Total joint replacement knee surgery, other knee surgery, meniscus tear, or ACL tear in the past 12 months * On a waiting list for total joint replacement * Severely impaired hearing or speech * Pregnant or planning to become pregnant in the next 8 weeks * Inability to speak English * Serious or terminal illness as indicated by referral to hospice or palliative care * Nursing home residence * Inability to ride a stationary bike * Any other health problems that would prohibit safe participation in the study.

Design outcomes

Primary

MeasureTime frame
Feasibility - proportion of potential participants screened for the study who are enrolledbaseline
Feasibility - retention: proportion of enrolled participants retained at 6-weeks post testing6 weeks

Secondary

MeasureTime frameDescription
Adherence: total number of training weeks completed6 weeks
Whole body metabolism measured by insulin6 weeks
Whole body metabolism measured by amino acids6 weeks
Whole body metabolism measured by free fatty acids6 weeks
Whole body metabolism measured by an oral glucose tolerance test6 weeks
Compliance: average number of training session completed per week6 weeks
Change in Pain score from baseline to 6 weeksbaseline, 6 weeksDetermined from WOMAC pain subscale (range 0-20)
Change in symptomatic burden score from baseline to 6 weeksbaseline, 6 weeksDetermined from the total WOMAC (range 0-96)
Cardiorespiratory Fitness from peak oxygen consumption test6 weeks
Knee Strength (extensors and flexors) from dynamometry6 weeks
Body Composition from dual energy x-ray absorptiometry6 weeks
Inflammation measured from interleukin-6 and tumor necrosis factor alpha6 weeks
Adherence: total number of training session completed per week6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026